PIH Applauds Breakthrough in Access to Key MDR-TB Drug
Posted on Oct 1, 2023
PIH CEO Dr. Sheila Davis shares her thoughts on what it will mean to have access to generic version's of Johnson & Johnson's bedaquiline, a key drug in the global fight against tuberculosis.